GSR and central nervous system cancer: Silencing of Prx II results oxidized environment by reducing the ratio between reduced and oxidized glutathione in glioma cells and inhibiting the reduction of GSSG to GSH by decreased activities of antioxidant enzyme, glutathione reductase.